AMS:ULVR 30 November 2025

March 21, 2026, 1:21 AM EDT. Pfizer Ltd, the Indian arm of Pfizer Inc., is experiencing share price volatility on NSE and BSE due to sector-wide challenges and strategic shifts by its global parent. The stock trades near ?4,738, down 4% year-over-year, underperforming the Nifty Pharma index. Investor concerns include regulatory changes, supply chain issues, and premium valuations with a high price-to-earnings ratio over 177. Despite recent modest gains and vaccine launches like the 20-valent Pneumococcal vaccine, Pfizer Ltd faces execution risks within India's complex pharma landscape. Its market cap stands around ?24,300 crore. European investors, especially in Germany, Austria, and Switzerland, should monitor developments closely amid India's evolving healthcare market and regulatory environment.